Vaishali Pharma Limited

NSE:VAISHALI.NS

18.75 (INR) • At close November 5, 2024
Bedrijfsnaam Vaishali Pharma Limited
Symbool VAISHALI.NS
Munteenheid INR
Prijs 18.75
Beurswaarde 2,009,850,000
Dividendpercentage 0%
52-weken bereik 12.49 - 24.91
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Atul Arvind Vasani
Website https://www.vaishalipharma.com

An error occurred while fetching data.

Over Vaishali Pharma Limited

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company

Vergelijkbare Aandelen

Aarey Drugs & Pharmaceuticals Limited logo

Aarey Drugs & Pharmaceuticals Limited

AAREYDRUGS.NS

62.78 INR

Lotus Eye Hospital and Institute Limited logo

Lotus Eye Hospital and Institute Limited

LOTUSEYE.NS

69.89 INR

Alpa Laboratories Limited logo

Alpa Laboratories Limited

ALPA.NS

111.64 INR

Bal Pharma Limited logo

Bal Pharma Limited

BALPHARMA.NS

123.23 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)